Analysis on diagnosis and treatment of coronavirus disease 2019(COVID-19)

doi:10.3969/j.issn.2095-3755.2020.01.003

Abstract

Abstract:

The novel coronavirus pneumonia (also named as coronavirus disease 2019 (COVID-19) By WHO) has been causing a severe public health problem in China. Now the epidemic has been posing great emergency not only in China, but also to the public health system worldwide. More than 80000 confirmed cases in China and more than 100000 confirmed cases worldwide have been reported at the day of this manuscript. For enhancing the clinicians’ understanding of COVID-19, we briefly summarized some main points of diagnosis and treatment from our experiences of COVID-19 patients care, literature review and recent diagnosis and treatment regimen. We hope to provide some references to clinicians when taking care of COVID-19 patients.

Key words: Coronavirus disease 2019 (COVID-19), Diagnosis, differential, Disease attributes, Drug therapy, Program evaluation, Comment

DENG Guo-fang, LEI Jian-ping. Analysis on diagnosis and treatment of coronavirus disease 2019(COVID-19)[J]. Journal of Tuberculosis and Lung Health , 2020, 9(1): 7-10. doi: 10.3969/j.issn.2095-3755.2020.01.003

References 13

[1]	World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance[EB/OL]. 2020- 01- 28. [2020-01-30]. .
[2]	中华人民共和国国家卫生健康委员会办公厅,中华人民共和国国家中医药管理局办公室. 关于印发新型冠状病毒肺炎诊疗方案(试行第七版)的通知[EB/OL]. 国卫办医函〔2020〕184号. 2020- 03- 03. [2020-03-05]. .
[3]	Xu Z, Shi L, Wang Y , et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med, 2020. pii: S2213-2600(20)30076-X. doi: 10.1016/S2213-2600(20) 30076-X.[Epub ahead of print].
[4]	Wang D, Hu B, Hu C , et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 2020. doi: 10.1001/jama.2020.1585.[Epub ahead of print].
[5]	Luo W, Yu H, Gou J , et al. Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19)[J/OL]. Preprints,2020: 2020020407. 2020-02-17. [2020-02-26]. .
[6]	Chen N, Zhou M, Dong X , et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020,395(10223):507-513.
[7]	Guo L, Wei D, Zhang X , et al. Clinical features predicting mortality risk in patients with viral pneumonia: The MuLBSTA score. Front Microbiol, 2019,10:2752. doi: 10.3389/fmicb.2019.02752.eCollection 2019.
[8]	Li Q, Guan X, Wu P , et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med, 2020. doi: 10.1056/NEJMoa2001316.[Epub ahead of print].
[9]	Huang C, Wang Y, Li X , et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020,395(10223):497-506.
[10]	Chan JF, Yuan S, Kok KH , et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 2020,395(10233):514-523.
[11]	刘又宁 . 关于新型冠状病毒感染疾病治疗药物的思考[J/OL]. 中华结核和呼吸杂志,2020,43. 2020-02-18.[2020-02-26]. .
[12]	赵建平, 胡轶, 杜荣辉 , 等. 新型冠状病毒肺炎糖皮质激素使用的建议[J/OL]. 中华结核和呼吸杂志,2020,43. 2020-02-08.[2020-02-26]. .
[13]	高占成, . 科学认识和科学管理是防控和救治新型冠状病毒肺炎的关键 [J/OL]. 中华结核和呼吸杂志,2020,43. 2020-02-05. [2020-02-21]. .

[1]	LIU Bo-fei, WANG Fang, LIU Bo-xia, MA Yu-jie, FENG Tao, XU Lin, ZHAO Gui-xia, HONG Yuan, LIU Guang-tian, ZHOU Pan, CAO Xiang-yuan. Analysis of characteristics of chest CT imaging and immune indexes in 84 COVID-19 patients [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(3): 220-225.
[2]	LIN Ming-gui, LIN Jin-lan, WEI Lai, ZHANG Ping, ZHOU Bi-qin, ZHANG Wen-yan, HUA Hao, ZHAO Wen-jing, NIE Guang-meng, SHU Li-nan, WANG Xiao-hui, CHEN Kai-li. Study on the prevention strategy of general hospital with fever clinic as the focus during the outbreak of COVID-19 [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(2): 109-111.
[3]	SHEN Cong, JIAO Lei, BAI Lu, ZHANG Yi-li, GUO You-min. Analysis of the dynamic evolution of Chest CT lesions quality and peripheral blood lymphocyte count in patients with coronavirus disease 2019 [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(2): 126-130.
[4]	JIN Min-lu, CHANG Yun-qing, QI Feng-ming, GUAN Xiao-gang, ZHENG Guan-hua, ZHAO Yong-hua, LI Zhen-qiang, LI Xiao-sheng, WANG Li-fen, WANG Fang, BAI Yin-jie. Clinical characteristics and effect analysis of 39 cases of 2019 novel Coronavirus-related pneumonia [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(2): 131-135.
[5]	YU Yan-yan, CHEN Zhen-hua, WANG Jue, LYU Yan, CHEN Zhong-nan, LIU Bin-bin, YI Song-lin, HU Pei-lei, TAN Yun-hong. Clinical characteristics and influencing factors of culture-positive pulmonary tuberculosis patients coinfected with non-tuberculous mycobacteria [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(2): 144-148.
[6]	WANG Li-hua, LIU Yan-yan. Clinical analysis of 27 neurobrucellosis cases misdiagnosed as tuberculosis meningitis [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(2): 183-185.
[7]	PENG Peng, YU Hui-shan, ZHOU Xin-hua. Clinical features and CT imaging diagnosis of novel coronavirus pneumonia [J]. Journal of Tuberculosis and Lung Health, 2020, 9(1): 11-15.
[8]	YU Hui-shan, QIN Li-xin, DING Chen-yu, LIU Jing, LI Bao-xue, LI Zheng-min. The analysis of imaging characteristics of high-resolution CT in 250 cases with coronavirus disease 2019 [J]. Journal of Tuberculosis and Lung Health, 2020, 9(1): 19-24.
[9]	HUANG Yi, WANG Si-han, ZHENG Chu-yun, LIU Yue, ZHANG Yao-hui. Ultrasonographic features of peripheral lung lesions at different stages in patients with novel coronavirus pneumonia [J]. Journal of Tuberculosis and Lung Health, 2020, 9(1): 25-31.
[10]	JIANG Ling, LUO Ting-ru, ZHOU Xiao-qi, TANG Na, MENG Chang-ping, QIAN Chun-fang. Evaluation of effectiveness of chemotherapy regimens with linezolid in treatment of severe tuberculous meningitis [J]. Journal of Tuberculosis and Lung Health, 2020, 9(1): 44-48.
[11]	SONG Min, FANG Wei-jun, HAN Yuan-yuan, FENG Hui-yong. Analysis of CT features of drug-resistant tuberculosis in children [J]. Journal of Tuberculosis and Lung Health, 2020, 9(1): 58-63.
[12]	LI Rong, MA Jin-bao, REN Fei, ZHANG Fan, TAN Gan-wen, ZHOU Jie, WU Yan-qin. Correlation between nutritional status and chest CT findings in patients with newly diagnosed smear positive pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(1): 17-23.
[13]	MAO Yi, CHEN Yi, WU Gui-hui, CHEN Jing. Analysis of the correlation between nutritional risk status and clinical characteristics of pulmonary tuberculosis patients [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(1): 24-28.
[14]	WANG Chun-ting, LI Ya-qi, MI Yan, MO Nian-chun, LIU Hong-yan, LE Xing, ZHOU Li, WU Bi-feng, HAN Shi-yun, BAI Li-qiong, ZHANG Chuan-fang. Monitoring of pulmonary function in patients with active tuberculosis during anti-tuberculosis treatment [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(1): 39-44.
[15]	LIU Chen, XU Xiao-liang, FU Ting-liang. Clinical characteristics and choices of treatment for lymphadenitis after BCG vaccination in infants [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(1): 78-81.